Heart Disease News and Research

Latest Heart Disease News and Research

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device, according to researchers at Henry Ford Hospital in Detroit.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

IPS Research joins SAFE-BioPharma Association

IPS Research Company, a major southwest clinical research investigator site located in Oklahoma City, OK, has joined SAFE-BioPharma Association and taken another step in the process of eliminating paper copies from its operations.

28 May 2010

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.

28 May 2010

Individuals with poor oral hygiene at increased risk of heart disease

Individuals who have poor oral hygiene have an increased risk of heart disease compared to those who brush their teeth twice a day, finds research published today on BMJ.com.

28 May 2010

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Oregon Health & Science University is partnering with the University of Oregon and Harvard Medical School to expedite basic science research into new and existing drugs and compounds that may prevent the complications associated with Fanconi anemia, an inherited condition that can lead to bone marrow failure and cancer.

28 May 2010

PCA-Rx represents next generation of chelation technology for ASD patients

According to the Center for Disease Control, autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. To give autism spectrum disorder sufferers a natural alternative to chelation therapy, Maxam Nutraceutics has introduced PCA-Rx.

28 May 2010

Zargis Medical launches live-streaming version of Telemed platform at ATA

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it launched the live-streaming version of its ZargisTelemed™ platform at last week's American Telemedicine Association Conference (ATA) in San Antonio, TX. The system allows healthcare professionals to share stethoscope sounds in real-time with colleagues located anywhere in the world through the Internet or a private network. This technology is cleared for sale in the U.S. and 36 other countries.

28 May 2010

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

CompuMed, Inc., a telemedicine and medical informatics company, reported its CardioGram® and OsteoGram® systems have been incorporated as core components of Visio Mobile Diagnostics' suite of telemedicine and digital x-ray-based healthcare services.

27 May 2010

HeartMate II left ventricular assist device also improves right side heart function

A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart, according to researchers at Henry Ford Hospital's Heart and Vascular Institute.

27 May 2010

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

Bio-Reference Laboratories, Inc. (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

SonoSite signs agreement to acquire privately held Visualsonics

SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt.

27 May 2010

InfraReDx's LipiScan IVUS Coronary Imaging System to be featured at EuroPCR 2010

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.

27 May 2010

Leading stem cell scientists to discuss on stem cell clinical trials for ALS and heart attack patients

The first Cedars-Sinai Regenerative Medicine Scientific Symposium, dedicated to furthering our ability to bring stem cell therapies from the laboratory to the patient bedside. The conference, led by Clive Svendsen, Ph.D., and Eduardo Marb-n, M.D., Ph.D., will highlight the most recent developments in leading-edge stem cell research and treatments for brain and heart diseases.

27 May 2010

Computer virus infects scientist

A scientist at the University of Reading has become the first person in the world to be infected by a computer virus.

27 May 2010

Dosage of statin drugs given to patients with heart disease should be monitored: Study

The type and dosage of statin drugs given to patients to treat heart disease should be proactively monitored as they can have unintended adverse effects, concludes a new study published on bmj.com.

27 May 2010

Pfizer plans recruitment halt to EMPHASIS-HF trial

Pfizer Inc. announced that it plans to halt recruitment to the EMPHASIS-HF trial early on the recommendations of the trial's independent Executive Steering Committee (ESC). The recommendations follow a second interim analysis by the independent Data Safety Monitoring Committee (DSMC) of the EMPHASIS-HF trial confirming the study has reached its primary efficacy endpoint early according to the protocol pre-defined stopping rules.

27 May 2010

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.

27 May 2010

Carl Zeiss launches ATLAS system for imaging of large-area specimens with nanometer resolution

Today, Carl Zeiss launches ATLAS™, a powerful hard- and software package, which, in combination with any scanning electron microscope from Carl Zeiss, enables quick and efficient imaging of large-area specimens with nanometer resolution.

27 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

Restricting salt intake helps control blood pressure in dialysis patients: Research

IPS Research joins SAFE-BioPharma Association

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Individuals with poor oral hygiene at increased risk of heart disease

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

PCA-Rx represents next generation of chelation technology for ASD patients

Zargis Medical launches live-streaming version of Telemed platform at ATA

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

HeartMate II left ventricular assist device also improves right side heart function

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

SonoSite signs agreement to acquire privately held Visualsonics

InfraReDx's LipiScan IVUS Coronary Imaging System to be featured at EuroPCR 2010

Leading stem cell scientists to discuss on stem cell clinical trials for ALS and heart attack patients

Computer virus infects scientist

Dosage of statin drugs given to patients with heart disease should be monitored: Study

Pfizer plans recruitment halt to EMPHASIS-HF trial

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

Carl Zeiss launches ATLAS system for imaging of large-area specimens with nanometer resolution

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Heart Disease News and Research

Latest Heart Disease News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in